Propanc Biopharma (PPCB) Total Debt (2011 - 2025)
Propanc Biopharma (PPCB) posted quarterly Total Debt of $120280.0 for Q4 2025, down 75.56% year-over-year from $492127.0 in Q4 2024, and up 12.44% quarter-over-quarter from $106968.0 in Q3 2025.
Propanc Biopharma (PPCB) Total Debt (2011 - 2025) Analysis & Trends
Propanc Biopharma (PPCB) has reported Total Debt for 15 consecutive years, with $120280.0 the latest figure, recorded in Q4 2025.
- In Q4 2025, Total Debt fell 75.56% year-over-year to $120280.0; the TTM figure through Dec 2025 stood at $120280.0 (down 75.56% YoY), while the FY2025 annual figure was $643548.0, up 40.52% from the prior year.
- Total Debt grew to $120280.0 in Q4 2025 per PPCB's latest filing, from $106968.0 in the prior quarter.
- Across five years, Total Debt topped out at $1.1 million in Q1 2022 and bottomed at $32076.0 in Q3 2021.
- Historically, Total Debt has averaged $513017.0 across 5 years, with a median of $509503.5 in 2024.
- Annual changes were most pronounced in 2021 — Total Debt tumbled 96.88% — and 2022, when it soared 2770.38%.
- Propanc Biopharma's Total Debt stood at $972670.0 in 2021, then tumbled by 88.11% to $115637.0 in 2022, then jumped by 525.11% to $722864.0 in 2023, then slumped by 31.92% to $492127.0 in 2024, then slumped by 75.56% to $120280.0 in 2025.
- Business Quant data shows PPCB's Total Debt at $120280.0 in Q4 2025, $106968.0 in Q3 2025, and $643548.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 1.99 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 591.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 1.07 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | - |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 546.77 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 9.34 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 770.36 Mn |
| 10 | Propanc Biopharma | 587,855.41 | 587,855.41 | - | 120,280.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 120,280.00 |
| Sep 30, 2025 | 106,968.00 |
| Jun 30, 2025 | 643,548.00 |
| Mar 31, 2025 | 532,491.00 |
| Dec 31, 2024 | 492,127.00 |
| Sep 30, 2024 | 526,880.00 |
| Jun 30, 2024 | 457,967.00 |
| Mar 31, 2024 | 629,879.00 |
| Dec 31, 2023 | 722,864.00 |
| Sep 30, 2023 | 426,024.00 |
| Jun 30, 2023 | 455,819.00 |
| Mar 31, 2023 | 95,057.00 |
| Dec 31, 2022 | 115,637.00 |
| Sep 30, 2022 | 913,641.00 |
| Jun 30, 2022 | 957,184.00 |
| Mar 31, 2022 | 1.08 Mn |
| Dec 31, 2021 | 972,670.00 |
| Sep 30, 2021 | 32,076.00 |
| Jun 30, 2021 | 33,347.00 |
| Mar 31, 2021 | 950,180.00 |